Praxis Precision Medicines, Inc. (PRAX)
321.17
-6.96
(-2.12%)
USD |
NASDAQ |
Nov 16, 11:23
Praxis Precision Medicines Debt to Equity Ratio : 0.0006 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0006 |
| June 30, 2026 | 0.0008 |
| March 31, 2026 | 0.001 |
| December 31, 2025 | 0.0001 |
| September 30, 2025 | 0.0013 |
| June 30, 2025 | 0.0019 |
| March 31, 2025 | 0.0024 |
| December 31, 2024 | 0.0031 |
| September 30, 2024 | 0.0043 |
| June 30, 2024 | 0.0046 |
| March 31, 2024 | 0.0097 |
| December 31, 2023 | 0.0358 |
| September 30, 2023 | 0.0318 |
| June 30, 2023 | 0.0285 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.0506 |
| December 31, 2022 | 0.046 |
| September 30, 2022 | 0.0355 |
| June 30, 2022 | 0.0285 |
| March 31, 2022 | 0.0224 |
| December 31, 2021 | 0.0172 |
| September 30, 2021 | 0.0149 |
| June 30, 2021 | 0.0135 |
| March 31, 2021 | 0.0022 |
| December 31, 2020 | 0.0027 |
| September 30, 2020 | 0.0087 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.0364 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioMarin Pharmaceutical, Inc. | 0.6723 |
| Ironwood Pharmaceuticals, Inc. | -3.459 |
| Xencor, Inc. | 0.2859 |
| IDEAYA Biosciences, Inc. | 0.0272 |
| ACADIA Pharmaceuticals, Inc. | 0.0518 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.312B |
| Total Liabilities (Quarterly) | 52.50M |
| Shareholders Equity (Quarterly) | 1.260B |
| Current Ratio | 14.53 |
| Net Debt Paydown Yield | 0.00% |